Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 8831
Gene Symbol: SYNGAP1
SYNGAP1
0.100 GeneticVariation phenotype CLINVAR
Entrez Id: 23394
Gene Symbol: ADNP
ADNP
0.100 GeneticVariation phenotype CLINVAR
Entrez Id: 166378
Gene Symbol: SPATA5
SPATA5
0.100 GeneticVariation phenotype CLINVAR
Entrez Id: 10075
Gene Symbol: HUWE1
HUWE1
0.100 GeneticVariation phenotype CLINVAR
Entrez Id: 1759
Gene Symbol: DNM1
DNM1
0.100 GeneticVariation phenotype CLINVAR
Entrez Id: 25792
Gene Symbol: CIZ1
CIZ1
0.100 GeneticVariation phenotype CLINVAR
Entrez Id: 64207
Gene Symbol: IRF2BPL
IRF2BPL
0.100 GeneticVariation phenotype CLINVAR
Entrez Id: 3492
Gene Symbol: IGH
IGH
0.070 GeneticVariation phenotype BEFREE Partial versus productive immunoglobulin heavy locus rearrangements in chronic lymphocytic leukemia: implications for B-cell receptor stereotypy. 21968789 2012
Entrez Id: 3492
Gene Symbol: IGH
IGH
0.070 GeneticVariation phenotype BEFREE To test the hypothesis that signaling through innate immunity receptors may influence the behavior of the malignant clone, we investigated the functional response triggered by the stimulation of TLRs and NOD2 in 67 CLL cases assigned to different subgroups on the basis of immunoglobulin heavy variable (IGHV ) gene usage, IGHV gene mutational status or B-cell receptor (BcR) stereotypy. 22437326 2012
Entrez Id: 3492
Gene Symbol: IGH
IGH
0.070 GeneticVariation phenotype BEFREE We studied the antigen-binding characteristics of 23 CLL-derived, recombinantly-expressed IGs with 5 pathogenic bacteria, determining that CLL IGs differ in bacterial reactivity based on IGHV gene use, mutation status, and association with IGHD and IGHJ genes ("stereotypy"). 27586592 2016
Entrez Id: 28402
Gene Symbol: IGHV3-69-1
IGHV3-69-1
0.040 GeneticVariation phenotype BEFREE To test the hypothesis that signaling through innate immunity receptors may influence the behavior of the malignant clone, we investigated the functional response triggered by the stimulation of TLRs and NOD2 in 67 CLL cases assigned to different subgroups on the basis of immunoglobulin heavy variable (IGHV ) gene usage, IGHV gene mutational status or B-cell receptor (BcR) stereotypy. 22437326 2012
Entrez Id: 102723407
Gene Symbol: LOC102723407
LOC102723407
0.040 GeneticVariation phenotype BEFREE To test the hypothesis that signaling through innate immunity receptors may influence the behavior of the malignant clone, we investigated the functional response triggered by the stimulation of TLRs and NOD2 in 67 CLL cases assigned to different subgroups on the basis of immunoglobulin heavy variable (IGHV ) gene usage, IGHV gene mutational status or B-cell receptor (BcR) stereotypy. 22437326 2012
Entrez Id: 28309
Gene Symbol: IGHV3OR16-7
IGHV3OR16-7
0.040 GeneticVariation phenotype BEFREE To test the hypothesis that signaling through innate immunity receptors may influence the behavior of the malignant clone, we investigated the functional response triggered by the stimulation of TLRs and NOD2 in 67 CLL cases assigned to different subgroups on the basis of immunoglobulin heavy variable (IGHV ) gene usage, IGHV gene mutational status or B-cell receptor (BcR) stereotypy. 22437326 2012
Entrez Id: 102724971
Gene Symbol: LOC102724971
LOC102724971
0.040 GeneticVariation phenotype BEFREE To test the hypothesis that signaling through innate immunity receptors may influence the behavior of the malignant clone, we investigated the functional response triggered by the stimulation of TLRs and NOD2 in 67 CLL cases assigned to different subgroups on the basis of immunoglobulin heavy variable (IGHV ) gene usage, IGHV gene mutational status or B-cell receptor (BcR) stereotypy. 22437326 2012
Entrez Id: 8936
Gene Symbol: WASF1
WASF1
0.010 GeneticVariation phenotype BEFREE Using a three-wave longitudinal neuroimaging design (N = 22, M<sub>age</sub>  = 13.08 years at Wave 1), this study examined if youth's stereotypes about teens modulate changes in their neural activation during cognitive control. 29336026 2018
Entrez Id: 28444
Gene Symbol: IGHV3-21
IGHV3-21
0.010 GeneticVariation phenotype BEFREE To investigate the IGHV3-21 frequency and the clinical impact of IGHV3-21 stereotypy, 337 newly diagnosed Swedish CLL patients from a population-based cohort were analyzed. 22464020 2012
Entrez Id: 1812
Gene Symbol: DRD1
DRD1
0.010 GeneticVariation phenotype BEFREE An Allosteric Potentiator of the Dopamine D1 Receptor Increases Locomotor Activity in Human D1 Knock-In Mice without Causing Stereotypy or Tachyphylaxis. 27811173 2017
Entrez Id: 2902
Gene Symbol: GRIN1
GRIN1
0.010 GeneticVariation phenotype BEFREE GRIN1 mutations cause encephalopathy with infantile-onset epilepsy, and hyperkinetic and stereotyped movement disorders. 25864721 2015
Entrez Id: 4208
Gene Symbol: MEF2C
MEF2C
0.400 Biomarker phenotype HPO
Entrez Id: 4208
Gene Symbol: MEF2C
MEF2C
0.400 Biomarker phenotype CTD_human Refining the phenotype associated with MEF2C haploinsufficiency. 20412115 2010
Entrez Id: 1392
Gene Symbol: CRH
CRH
0.300 Biomarker phenotype CTD_human Corticotropin-releasing hormone is a rapid and potent convulsant in the infant rat. 1914160 1991
Entrez Id: 7200
Gene Symbol: TRH
TRH
0.300 Biomarker phenotype CTD_human Distinct grooming patterns induced by intracerebroventricular injection of CRH, TRH and LHRH in male rats. 8736133 1996
Entrez Id: 2896
Gene Symbol: GRN
GRN
0.100 Biomarker phenotype HPO
Entrez Id: 55180
Gene Symbol: LINS1
LINS1
0.100 Biomarker phenotype HPO
Entrez Id: 5625
Gene Symbol: PRODH
PRODH
0.100 Biomarker phenotype HPO